Thrombocytopenia
Tick-borne Lone Star virus identified through new super-fast gene sequencing
The tick-borne Lone Star virus has been conclusively identified as part of a family of other tick-borne viruses called bunyaviruses, which often cause fever, respiratory problems and bleeding, according to ...
Diseases, Conditions, Syndromes
May 02, 2013 |
5 / 5 (1) |
0
|
Clinical trial finds new class of cancer drugs safe and effective
The safety and preliminary efficacy of a new class of tumor fighting drugs were reported today by Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials and the Translational Genomics Research Institute (TGen).
Cancer
Apr 09, 2013 |
5 / 5 (2) |
0
Mystery bleeding disorders could be unraveled by new research efforts
(Medical Xpress)—Platelet disorders are heavily underdiagnosed, little understood and cannot be cured. University of Birmingham researchers and the Birmingham Platelet Group are running a UK-wide clinical trial 'Genotyping ...
Medical research
Feb 11, 2013 |
5 / 5 (1) |
0
|
New drug improves survival in multiple myeloma relapse
Researchers at Moffitt Cancer Center and colleagues have investigated the safety, efficacy and the maximum tolerated dose of pomalidomide for patients with multiple myeloma who have disease relapsed after treatments with ...
Cancer
Jan 24, 2013 |
not rated yet |
0
Rituximab shows promise for clinical problems tied to antiphospholipid antibodies
Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease ...
Arthritis & Rheumatism
Nov 20, 2012 |
not rated yet |
0
|
Optimal dose suggested for dasatinib in ovarian cancer
(HealthDay)—A phase I trial of dasatinib combined with paclitaxel and carboplatin has determined the optimal dose of dasatinib and suggested some efficacy in women with advanced or recurrent ovarian cancer, ...
Cancer
Nov 19, 2012 |
5 / 5 (1) |
0
Discovery advances fight against phleboviruses
(Medical Xpress)—Researchers in the Life Sciences Institute at the University of Michigan have discovered how a particular type of virus hides and protects its genetic information from the immune system, ...
Medical research
Nov 07, 2012 |
5 / 5 (1) |
0
|
New MS drug proves effective where others have failed
A drug which 'reboots' a person's immune system has been shown to be an effective treatment for multiple sclerosis (MS) patients who have already failed to respond to the first drug with which they were treated (a 'first-line' ...
Neuroscience
Oct 31, 2012 |
5 / 5 (1) |
0
Chemo combo promising for pancreatic neuroendocrine tumors
(HealthDay) -- The combination of temozolomide and bevacizumab seems to benefit patients with advanced pancreatic neuroendocrine tumors (NETs), according to a study published online July 9 in the Journal of ...
Cancer
Jul 13, 2012 |
not rated yet |
0
Platelet drug shows clinical benefits for severe, unresponsive aplastic anemia
Eltrombopag, a drug that was designed to stimulate production of platelets from the bone marrow and thereby improve blood clotting, can raise blood cell levels in some people with severe aplastic anemia who have failed all ...
Diseases, Conditions, Syndromes
Jul 04, 2012 |
5 / 5 (2) |
0
|
Brentuximab vedotin effective in large-cell lymphoma
(HealthDay) -- More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma (ALCL) treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a complete ...
Cancer
May 24, 2012 |
not rated yet |
0
Chemo combination promising for multiple myeloma
(HealthDay) -- For patients with relapsed or refractory multiple myeloma, combination treatment with elotuzumab, lenalidomide, and low-dose dexamethasone is generally well tolerated, with encouraging response ...
Cancer
May 02, 2012 |
not rated yet |
0
New fractionated dosing regimen for anticancer drug significantly improves outcomes for older leukemia patients
Using fractionated doses of the targeted anticancer drug gemtuzumab ozogamicin allows for safer delivery of the drug into patients aged 50-70 years with acute myeloid leukaemia (AML) and substantially improves their outcomes. ...
Cancer
Apr 04, 2012 |
5 / 5 (1) |
0
SU2C partnership results in new, potent epigenetic drug for myelodysplastic syndromes, leukemia
As a result of collaboration between academic and pharmaceutical scientists, made possible by a Stand Up To Cancer research grant, researchers may have discovered a new, potent epigenetic drug that could safely alter the ...
Cancer
Apr 02, 2012 |
5 / 5 (1) |
0
Two targeted therapies act against Ewing's sarcoma tumors
A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson ...
Cancer
Apr 01, 2012 |
5 / 5 (1) |
0
|
Thrombocytopenia (or thrombopenia) is a relative decrease of platelets in blood.
A normal human platelet count ranges from 150,000 to 450,000 platelets per microlitre of blood. These limits are determined by the 2.5th lower and upper percentile, so values outside this range do not necessarily indicate disease. One common definition of thrombocytopenia is a platelet count below 50,000 per microlitre.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Latest Spotlight News
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
Brain can be trained in compassion, study shows
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.
Do salamanders hold the solution to regeneration?
Salamanders' immune systems are key to their remarkable ability to regrow limbs, and could also underpin their ability to regenerate spinal cords, brain tissue and even parts of their hearts, scientists have ...
Hormone levels may provide key to understanding psychological disorders in women
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
Multiple research teams unable to confirm high-profile Alzheimer's study
Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.
The compound in the Mediterranean diet that makes cancer cells 'mortal'
New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death. By altering a very specific step in gene regulation, this compound essentially re-educates cancer ...
Brain uses internal 'average voice' prototype to identify who is talking
(Medical Xpress)—The human brain is able to identify individuals' voices by comparing them against an internal 'average voice' prototype, according to neuroscientists.
Controlling mood through the motions of mitochondria
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...
Motion quotient: IQ predicted by ability to filter motion (w/ video)
A brief visual task can predict IQ, according to a new study. This surprisingly simple exercise measures the brain's unconscious ability to filter out visual movement. The study shows that individuals whose ...
Slowing the aging process—only with antibiotics
Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.
